Year: 2013
Type: article
Abstract: Influenza A (H7N9) emerged earlier this year as a health threat in China. Efforts to develop a vaccine are under way. This letter presents initial phase 1 clinical data on the safety and immunogenicity of a candidate vaccine.
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1313186
Institution: Novavax (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1996415437
